Authors:
LIVESLEY MA
BAXTER IA
LAMBERT PA
GOVAN JRW
WELLER PH
LACEY DE
ALLISON DG
GIWERCMAN B
HOIBY N
Citation: Ma. Livesley et al., SUBSPECIFIC DIFFERENTIATION OF BURKHOLDERIA-CEPACIA ISOLATES IN CYSTIC-FIBROSIS, Journal of Medical Microbiology, 47(11), 1998, pp. 999-1006
Citation: T. Larsen et B. Giwercman, RESISTANCE OF PORPHYROMONAS-GINGIVALIS IN BIOFILMS TO DOXYCYCLINE ANDMETRONIDAZOLE, Journal of dental research, 77, 1998, pp. 2850-2850
Authors:
JENSEN ET
GIWERCMAN B
OJENIYI B
BANGSBORG JM
HANSEN A
KOCH C
FIEHN NE
HOIBY N
Citation: Et. Jensen et al., EPIDEMIOLOGY OF PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS AND THE POSSIBLE ROLE OF CONTAMINATION BY DENTAL EQUIPMENT, The Journal of hospital infection, 36(2), 1997, pp. 117-122
Authors:
PETERSEN TD
CIOFU O
PRESSLER T
GIWERCMAN B
PEDERSEN SS
HOIBY N
Citation: Td. Petersen et al., QUANTITATIVE-ANALYSIS OF THE IGG AND IGG SUBCLASS IMMUNE-RESPONSES TOCHROMOSOMAL PSEUDOMONAS-AERUGINOSA BETA-LACTAMASE IN SERUM FROM PATIENTS WITH CYSTIC-FIBROSIS BY WESTERN BLOTTING AND LASER-SCANNING DENSITOMETRY, Thorax, 51(7), 1996, pp. 733-738
Authors:
CIOFU O
GIWERCMAN B
WALTERRASMUSSEN J
PRESSLER T
PEDERSEN SS
HOIBY N
Citation: O. Ciofu et al., ANTIBODIES AGAINST PSEUDOMONAS-AERUGINOSA CHROMOSOMAL BETA-LACTAMASE IN PATIENTS WITH CYSTIC-FIBROSIS ARE MARKERS OF THE DEVELOPMENT OF RESISTANCE OF PSEUDOMONAS-AERUGINOSA TO BETA-LACTAMS, Journal of antimicrobial chemotherapy, 35(2), 1995, pp. 295-304
Citation: O. Ciofu et al., DEVELOPMENT OF ANTIBIOTIC-RESISTANCE IN PSEUDOMONAS-AERUGINOSA DURING2 DECADES OF ANTIPSEUDOMONAL TREATMENT AT THE DANISH-CF-CENTER, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 102(9), 1994, pp. 674-680
Authors:
REIMERT CM
GIWERCMAN B
HOIBY N
KHARAZMI A
Citation: Cm. Reimert et al., EOSINOPHIL CATIONIC PROTEIN IN SPUTUM FROM CYSTIC-FIBROSIS PATIENTS WITH PSEUDOMONAS-AERUGINOSA INFECTIONS, Lancet, 344(8935), 1994, pp. 1504-1505